J Gynecol Oncol.  2008 Sep;19(3):181-184. 10.3802/jgo.2008.19.3.181.

Uterine corpus involvement as well as histologic type is an independent predictor of ovarian metastasis in uterine cervical cancer

• Kim MJ
• Chung HH
• Kim JW
• Park NH
• Song YS
• Kang SB

• KMID: 2173399
• DOI: http://doi.org/10.3802/jgo.2008.19.3.181

Abstract

OBJECTIVE
This study aimed to investigate the independent risk factors for ovarian metastasis in cervical cancer. METHODS: Among 1,040 consecutive patients who underwent operation for cervical cancer at our institution from January 1998 to July 2007, a total of 625 patients had both ovaries removed during primary operation were retrospectively selected by medical records. In order to determine clinicopathological risk factors for ovarian metastasis, we analyzed patients' demographics, FIGO stage, and other pathologic findings. The Chi-square or Fisher's extract tests were used to compare any association of clinicopathologic variables with ovarian metastasis. For multivariate analysis, the log regression models were used to determine independent predictors for ovarian metastasis. RESULTS: Overall, ovarian metastasis was detected in fourteen (2.2%) patients: two of 473 patients with squamous cell carcinoma (0.4%) and twelve of 151 patients with non-squamous cell carcinoma (7.9%), respectively (p<0.0001). Univariate analysis represents age (< or =45 vs. >45 years: p=0.347), histologic types (squamous vs. non-squamous, p<0.0001), FIGO stages (IA1-IIA < or =4 cm vs. IB2-IIB >4 cm, p=0.054), stromal invasion (< or =1/2 vs. >1/2, p=0.788), lymph node metastasis (positive vs. negative, p=0.007), parametrium (involved vs. uninvolved, p=0.145), upper vagina (involved vs. uninvolved, p=0.003), uterine corpus (involved vs. uninvolved, p<0.0001), and margin status (involved vs. uninvolved, p=0.017). By multivariate analysis, uterine corpus involvement was the only independent risk factor for ovarian metastasis (p=0.008), in addition to histologic types (p<0.0001). CONCLUSION: Based on our study, uterine involvement of cervical cancer is an independent predictor for ovarian metastasis, except histologic types. Ovarian preservation in cervical cancer may be safely performed only when no involvement of uterine corpus is present.

Keyword

Ovarian metastasis; Cervical cancer; Squamous cell carcinoma; Adenocarcinoma

MeSH Terms

Adenocarcinoma
Carcinoma, Squamous Cell
Demography
Female
Humans
Lymph Nodes
Medical Records
Multivariate Analysis
Neoplasm Metastasis
Ovary
Retrospective Studies
Risk Factors
Uterine Cervical Neoplasms
Vagina

Figure

• 

  Fig. 1 Overview of study population. SCC: squamous cell carcinoma.

Reference

1. Chung HH, Jang MJ, Jung KW, Won YJ, Shin HR, Kim JW, et al. Cervical cancer incidence and survival in Korea: 1993-2002. Int J Gynecol Cancer. 2006. 16:1833–1838.

2. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: A 24-year population-based study. Gynecol Oncol. 2000. 78:97–105.

3. Benedetti-Panici P, Maneschi F, D'Andrea G, Cutillo G, Rabitti C, Congiu M, et al. Early cervical carcinoma: The natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study. Cancer. 2000. 88:2267–2274.

4. McCALL ML, Keaty EC, Thompson JD. Conservation of ovarian tissue in the treatment of carcinoma of the cervix with radical surgery. Am J Obstet Gynecol. 1958. 75:590–600.

5. Sutton GP, Bundy BN, Delgado G, Sevin BU, Creasman WT, Major FJ, et al. Ovarian metastases in stage IB carcinoma of the cervix: A Gynecologic Oncology Group study. Am J Obstet Gynecol. 1992. 166(1 Pt 1):50–53.

6. Landoni F, Zanagnolo V, Lovato-Diaz L, Maneo A, Rossi R, Gadducci A, et al. Ovarian metastases in early-stage cervical cancer (IA2-IIA): A multicenter retrospective study of 1965 patients (a Cooperative Task Force study). Int J Gynecol Cancer. 2007. 17:623–628.

7. Shimada M, Kigawa J, Nishimura R, Yamaguchi S, Kuzuya K, Nakanishi T, et al. Ovarian metastasis in carcinoma of the uterine cervix. Gynecol Oncol. 2006. 101:234–237.

8. Singleton HM, Orr JW. Cancer of the cervix. 1995. Philadelphia: JB Lippincott Company.

9. Wu HS, Yen MS, Lai CR, Ng HT. Ovarian metastasis from cervical carcinoma. Int J Gynaecol Obstet. 1997. 57:173–178.

10. Tabata M, Ichinoe K, Sakuragi N, Shiina Y, Yamaguchi T, Mabuchi Y. Incidence of ovarian metastasis in patients with cancer of the uterine cervix. Gynecol Oncol. 1987. 28:255–261.

11. Natsume N, Aoki Y, Kase H, Kashima K, Sugaya S, Tanaka K. Ovarian metastasis in stage IB and II cervical adenocarcinoma. Gynecol Oncol. 1999. 74:255–258.

12. Nakanishi T, Wakai K, Ishikawa H, Nawa A, Suzuki Y, Nakamura S, et al. A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol. 2001. 82:504–509.